Aclarion logo
Aclarion
ACON | NASDAQ
Chart Builder DCF Calculator
$1.39
-$0.17 (-10.74%)
At close: Nov 16, 2026, 4:00 PM ET
$1.44
+$0.05 (+3.53%)
After-hours: Nov 16, 2026, 7:57 PM ET

Aclarion Company Profile

Company profile explained

Company Profile

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Key Executives

Name Position
Brent Ness Chief Executive Officer, President & Director
Gregory A. Gould Chief Financial Officer
Jeffrey John Thramann Executive Chairman
Ryan Bond Chief Strategy Officer

Latest SEC Filings

Date Type Title
Aug 19, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 06, 2026 10-Q Quarterly Report
Jul 09, 2026 S-8 Filing
Jun 12, 2026 4 Filing
Jun 12, 2026 4 Filing
View All SEC Filings ➞
Aclarion
Aclarion logo
Country United States
IPO Date Apr 22, 2022
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 11
CEO Brent Ness

Contact Details

8181 Arista Place Broomfield, California 80021 United States

Stock Details

Ticker Symbol ACON
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001635077
CUSIP Number 655187409
ISIN Number US6551874091
SIC Code 8071

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.